Scientific advances in human genome editing have proven that somatic cell genome editing holds great potential to treat or maybe even cure genetic diseases. During the panel, Scientific Advances in Genome Editing: Where Are We Today?, panelists shared insights on how recent advances are…

Jamie Dimon, chairman and CEO of JPMorgan Chase & Co., headlined a keynote address this morning at the 2019 BIO International Convention. He chatted with Jim Greenwood, president and CEO of BIO, about what drives him, what he learned from fighting throat cancer and how he would fix some of our…

A native of Wilmington, Delaware (Philadelphia’s neighbor to the south), and the child of two scientists, Stephen Tang was well aware of Philly’s University City Science Center, the nation’s first and largest urban research park. Little did he know that he would serve as its CEO for 10 years and in…

Drug overdose deaths, including those involving opioids, reached 42,000 in 2016 (CDC), prompting a national response from the healthcare community to the sprawling crisis. The rise of opioid deaths appears to have occurred in three waves: first prescription opioids, followed by heroin, and most…

Uncertainty breeds delay of innovation and volatility of markets. We are certainly seeing this play out amid these tense times between the U.S. and China, as both sides seem intent on ratcheting up aggressive trade practices. Day one at the BIO International Convention’s China Summit included Josh…

Back in 1990, an experimental new treatment represented a bright light of hope for Ashanthi De Silva, who was just four at the time and became the first human to receive gene therapy. She was born with a crippled immune system due to inheriting two faulty copies of the gene responsible for…

As BIO’s President and CEO, who proudly represented the Philadelphia suburbs in Congress for 12 years, I am delighted to welcome you to the city I love for the 2019 BIO International Convention – our industry’s largest annual gathering. Philadelphia was the very first capital of the United States…

Newborn screening is recognized as an essential, preventive public health program for early identification of disorders in newborns. Screening programs began with one man, Dr. Robert Guthrie, who in the 1960's developed a screening test for phenylketonuria (PKU), the first disorder for which…

The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, or one conversation for a small, emerging biotech to change the way we treat and cure diseases for generations to come. Recognizing the potential and promise of early-stage companies for addressing unmet…